These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5968072)

  • 1. Inhibition of drug metabolism. II. Metabolism of 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A).
    Anders MW; Alvares AP; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):328-34. PubMed ID: 5968072
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of drug metabolism. IV. Induction of drug metabolism by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and 2,4-dichloro-6-phenylphenoxyethylamine HBr (Lilly 18947) and the effect of induction on the inhibitory properties of SKF 525-A type compounds.
    Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):341-6. PubMed ID: 5968074
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of drug metabolism. I. Kinetics of the inhibition of the N-demethylation of ethylmorphine by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and related compounds.
    Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):319-27. PubMed ID: 5968071
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE; Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract]   [Full Text] [Related]  

  • 5. 2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) revisited: comparative cytochrome P450 inhibition in human liver microsomes by SKF525A, its metabolites, and SKF-acid and SKF-alcohol.
    Franklin MR; Hathaway LB
    Drug Metab Dispos; 2008 Dec; 36(12):2539-46. PubMed ID: 18799803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of chlorpromazine by liver microsomal enzyme systems.
    Coccia PF; Westerfeld WW
    J Pharmacol Exp Ther; 1967 Aug; 157(2):446-58. PubMed ID: 6039835
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of an inhibitor of hepatic drug metabolism, 2-diethylaminoethyl-2,2-diphenylvalerate HCl (SKF 525-A), on thyroxine metabolism in the rat.
    Nakamura Y; Bellamy G; Green WL
    Endocrinology; 1981 Apr; 108(4):1519-36. PubMed ID: 7472282
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitory effect of 2-diethylaminoethyl 2,2-diphenylvalerate hydrochloride (SKF 525-A) on aromatic hydroxylation and phenolic glucuronidation.
    Ikeda M; Tanaka S; Katayama T
    Mol Pharmacol; 1968 Jan; 4(1):38-43. PubMed ID: 5640778
    [No Abstract]   [Full Text] [Related]  

  • 9. The delay of the behavioral effects of 9 -tetrahydrocannabinol in rats by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A).
    Peterson DW; Cohen GM; Sparber SB
    Life Sci I; 1971 Dec; 10(24):1381-6. PubMed ID: 5146321
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism of paraldehyde to acetaldehyde by rat liver microsomes.
    Zera RT; Nagasawa HT
    Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):531-41. PubMed ID: 7323448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidation of indene in liver microsomes.
    Leibman KC; Ortiz E
    Mol Pharmacol; 1968 May; 4(3):201-7. PubMed ID: 4385610
    [No Abstract]   [Full Text] [Related]  

  • 12. Species difference in the inhibition of drug metabolism in liver microsomes by SKF 525A.
    Kato R; Takayanagi M
    Jpn J Pharmacol; 1966 Mar; 16(1):127-8. PubMed ID: 5297500
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of repeated administration of rat 2-diethylaminoethyl-2-2-diphenylvalerate-HCI (SKF 525 A) on liver.
    Fernández G; Villarruel MC; Bernacchi A; de Castro CR; Castro JA
    Toxicology; 1981; 20(2-3):185-93. PubMed ID: 6167027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation and excretion of methylcyclopentadienyl manganese tricarbonyl in the rat.
    Hanzlik RP; Bhatia P; Stitt R; Traiger GJ
    Drug Metab Dispos; 1980; 8(6):428-33. PubMed ID: 6109612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride (SKF 525-A) on sulphacetamide distribution and excretion in rats.
    Marchand C; Nadeau D
    Br J Pharmacol; 1973 Jan; 47(1):69-76. PubMed ID: 4717021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo disposition and metabolism by liver and enterocyte microsomes of the antitubercular drug rifabutin in rats.
    Koudriakova T; Iatsimirskaia E; Tulebaev S; Spetie D; Utkin I; Mullet D; Thompson T; Vouros P; Gerber N
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1300-9. PubMed ID: 8968354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of saccharin in biological materials by gas-liquid chromatography.
    Daun RJ
    J Assoc Off Anal Chem; 1971 Sep; 54(5):1140-5. PubMed ID: 5151675
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatobiliary excretion of berberine.
    Tsai PL; Tsai TH
    Drug Metab Dispos; 2004 Apr; 32(4):405-12. PubMed ID: 15039293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new mode of action of SKD 525-A on morphine disposition studied by segmented retrograde intrabiliary injection (SRII) in the isolated in situ perfused rat liver.
    Imamura T; Fujimoto JM
    J Pharmacol Exp Ther; 1980 Oct; 215(1):122-6. PubMed ID: 7452478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of thiotepa antitumor activity in vivo by alteration of liver cytochrome P450-catalyzed drug metabolism.
    Chang TK; Chen G; Waxman DJ
    J Pharmacol Exp Ther; 1995 Jul; 274(1):270-5. PubMed ID: 7616408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.